Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ABIONYX Pharma SA (609.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.8340-0.0160 (-0.86%)
At close: 08:01AM CET
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
3,278
675
0
0
Cost of Revenue
2,954
416
0
0
Gross Profit
324
259
0
0
Operating Expense
6,145
6,211
2,968
2,524
Operating Income
-5,821
-5,952
-2,968
-2,524
Net Non Operating Interest Income Expense
23
148
1,043
4,436
Pretax Income
-5,826
-5,822
-1,886
1,888
Tax Provision
0
0
0
38
Net Income Common Stockholders
-5,826
-5,822
-1,886
1,849
Diluted NI Available to Com Stockholders
-5,826
-5,822
-1,886
1,849
Basic EPS
-
-0.23
-0.08
0.09
Diluted EPS
-
-0.23
-0.08
0.09
Basic Average Shares
-
24,880
22,508
20,599
Diluted Average Shares
-
25,919
23,488
21,121
Total Operating Income as Reported
-5,821
-5,952
-2,968
-2,525
Total Expenses
9,099
6,627
2,968
2,524
Net Income from Continuing & Discontinued Operation
-5,826
-5,822
-1,886
1,849
Normalized Income
-5,826
-5,822
-1,886
1,849
Interest Income
6
4
55
200
Interest Expense
15
8
0
350
Net Interest Income
23
148
1,043
4,436
EBIT
-5,811
-5,814
-1,886
2,238
EBITDA
-5,637
-
-
-
Reconciled Cost of Revenue
2,954
416
0
0
Reconciled Depreciation
174
119
22
13
Net Income from Continuing Operation Net Minority Interest
-5,826
-5,822
-1,886
1,849
Normalized EBITDA
-5,637
-5,695
-1,864
2,251
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement